Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-25 · accession 0001712276-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | 2025-11-25 | RXRX | Taylor Ben R | CFO | F - Tax | $4.03 | -2,271 | 790.0K | -0.3% | -$9,152 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-11-25 | F | D | 2,271 | $4.03 | 789,990 | D | — | — |